Literature DB >> 15520178

Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice.

Hiroyuki Mutoh1, Shinji Sakurai, Kiichi Satoh, Kiichi Tamada, Hiroto Kita, Hiroyuki Osawa, Takeshi Tomiyama, Yukihiro Sato, Hironori Yamamoto, Norio Isoda, Toru Yoshida, Kenichi Ido, Kentaro Sugano.   

Abstract

In the progression of chronic gastritis, gastric mucosal cells deviate from the normal pathway of gastric differentiation to an intestinal phenotype. Many epidemiologic studies have found an association between the formation of intestinal metaplasia and the development of gastric carcinoma. However, there is no direct evidence that shows intestinal metaplasia is a precursor lesion of gastric carcinoma, to date. We periodically examined the intestinal metaplastic mucosa of Cdx2-transgenic mice we have previously generated. Gastric polyps developed from intestinal metaplastic mucosa in all stomachs of Cdx2-transgenic mice examined. These gastric polyps consisted of intestinal-type adenocarcinoma that invaded the submucosa and muscularis propria and occasionally spread into the subserosa. p53 and APC gene mutations were recognized in the adenocarcinomas. The participation of APC and p53 gene mutations in gastric carcinogenesis from the intestinal metaplasia was verified by the Cdx2-transgenic mice, carrying Apc(Min) mutation or p53 deficiency, that developed gastric polyps much earlier than Cdx2 alone. We successfully showed that long-term intestinal metaplasia induces invasive gastric carcinoma. These results indicate that intestinal metaplasia itself plays a significant role in the genesis and progression of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520178     DOI: 10.1158/0008-5472.CAN-04-1617

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

Review 1.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 2.  Stomach development, stem cells and disease.

Authors:  Tae-Hee Kim; Ramesh A Shivdasani
Journal:  Development       Date:  2016-02-15       Impact factor: 6.868

3.  Endoscopic tri-modal imaging improves detection of gastric intestinal metaplasia among a high-risk patient population in Singapore.

Authors:  Jimmy So; Andrea Rajnakova; Yiong-Huak Chan; Amy Tay; Nilesh Shah; Manuel Salto-Tellez; Ming Teh; Noriya Uedo; Uedo Noriya
Journal:  Dig Dis Sci       Date:  2013-09-01       Impact factor: 3.199

4.  Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer.

Authors:  Kentaro Sugano
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

5.  High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei.

Authors:  Kukka Heiskala; Jill Giles-Komar; Marja Heiskala; Leif C Andersson
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

6.  siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells.

Authors:  Xiao-Tong Wang; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

7.  Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Authors:  Ki Taek Nam; Hyuk-Joon Lee; Hoyin Mok; Judith Romero-Gallo; James E Crowe; Richard M Peek; James R Goldenring
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

Review 8.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Expression of maspin is associated with the intestinal type of gastric adenocarcinoma.

Authors:  Seong Man Kim; Seong Jin Cho; Woo Young Jang; Duck Hwan Kim; Hyung Sik Shin; Myoung Kuk Jang; Hak Yang Kim; Eun Sook Nam
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

Review 10.  Helicobacter pylori CagA: a critical destroyer of the gastric epithelial barrier.

Authors:  Jia Wu; Song Xu; Yongliang Zhu
Journal:  Dig Dis Sci       Date:  2013-02-20       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.